Login to Your Account



Bench Press


Monday, October 17, 2011
An international team led by scientists from the Wellcome Trust Sanger Institute and the University of Cambridge has managed to derive induced pluripotent stem (iPS) cells from a patient with a deficiency in enzyme alpha-1-antitrypsin, which leads to both lung emphysema and liver cirrhosis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription